COO Stock Price, Chart, Stats & News

The Cooper Companies, Inc.
Save
12.69B
Market cap
55.13x
Current P/E
14.51x
Forward P/E
COO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 64.24% |
Operating margin | 17.19% |
Pretax margin | 14.58% |
Net margin | 9.67% |
Effective tax rate | 33.70% |
ROA | 3.23% |
ROE | 4.83% |
D/E | 0.30x |
Interest coverage ratio | 6.76x |
COO valuation
P/E | 55.13x |
P/S | 3.28x |
P/B | 1.64x |
P/CF | 15.84x |
P/FCF | 27.71x |
P/OCF | 15.84x |
PEG | 4.59x |
EV multiple | 11.68x |
About
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue.
Similar securities
Based on sector and market capitalization
Report issue











